nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A call for Essays: stories from the frontline during the COVID-19 pandemic
|
Woolven, Sophie |
|
|
8 |
11 |
p. 1074 |
artikel |
2 |
Amazon fires coincide with increased respiratory illnesses in indigenous populations
|
Alves, Lise |
|
|
8 |
11 |
p. e84 |
artikel |
3 |
Asthma in children during the COVID-19 pandemic: lessons from lockdown and future directions for management
|
Gupta, Atul |
|
|
8 |
11 |
p. 1070-1071 |
artikel |
4 |
Can perturbations in microbial maturation cause asthma?
|
Stokholm, Jakob |
|
|
8 |
11 |
p. 1063-1065 |
artikel |
5 |
Correction to Lancet Respir Med 2020; 8: 1154–58
|
|
|
|
8 |
11 |
p. e78 |
artikel |
6 |
Correction to Lancet Respir Med 2020; 8: 786–94
|
|
|
|
8 |
11 |
p. e78 |
artikel |
7 |
COVID-19 recovery: potential treatments for post-intensive care syndrome
|
Bangash, Mansoor N |
|
|
8 |
11 |
p. 1071-1073 |
artikel |
8 |
COVID-19 testing in the UK
|
The Lancet Respiratory Medicine, |
|
|
8 |
11 |
p. 1061 |
artikel |
9 |
COVID-19 vaccine trials in Africa
|
Makoni, Munyaradzi |
|
|
8 |
11 |
p. e79-e80 |
artikel |
10 |
Decreasing antibiotic use, the gut microbiota, and asthma incidence in children: evidence from population-based and prospective cohort studies
|
Patrick, David M |
|
|
8 |
11 |
p. 1094-1105 |
artikel |
11 |
Discovery of lung cancer after an injury on holiday
|
Kirby, Tony |
|
|
8 |
11 |
p. 1075 |
artikel |
12 |
ECMO for severe ARDS associated with COVID-19: now we know we can, but should we?
|
Shekar, Kiran |
|
|
8 |
11 |
p. 1066-1068 |
artikel |
13 |
2020 European Respiratory Society International Virtual Congress
|
Venkatesan, Priya |
|
|
8 |
11 |
p. e82-e83 |
artikel |
14 |
Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study
|
Schmidt, Matthieu |
|
|
8 |
11 |
p. 1121-1131 |
artikel |
15 |
Human recombinant soluble ACE2 in severe COVID-19
|
Zoufaly, Alexander |
|
|
8 |
11 |
p. 1154-1158 |
artikel |
16 |
Imaging research in fibrotic lung disease; applying deep learning to unsolved problems
|
Walsh, Simon L F |
|
|
8 |
11 |
p. 1144-1153 |
artikel |
17 |
Inhaled corticosteroids and COVID-19-related mortality: confounding or clarifying?
|
Singh, Dave |
|
|
8 |
11 |
p. 1065-1066 |
artikel |
18 |
Pharmacotherapy for pulmonary arterial hypertension
|
Burki, Talha Khan |
|
|
8 |
11 |
p. e81 |
artikel |
19 |
Pooled saliva samples for COVID-19 surveillance programme
|
Fogarty, Andrew |
|
|
8 |
11 |
p. 1078-1080 |
artikel |
20 |
Prevalence and risk factors of small airway dysfunction, and association with smoking, in China: findings from a national cross-sectional study
|
Xiao, Dan |
|
|
8 |
11 |
p. 1081-1093 |
artikel |
21 |
Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform
|
Schultze, Anna |
|
|
8 |
11 |
p. 1106-1120 |
artikel |
22 |
Small airway dysfunction: not so silent after all?
|
Papi, Alberto |
|
|
8 |
11 |
p. 1062-1063 |
artikel |
23 |
Targeting MET amplification in EGFR-mutant non-small-cell lung cancer
|
Rosell, Rafael |
|
|
8 |
11 |
p. 1068-1070 |
artikel |
24 |
Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial
|
Wu, Yi-Long |
|
|
8 |
11 |
p. 1132-1143 |
artikel |
25 |
The Russian vaccine for COVID-19
|
Burki, Talha Khan |
|
|
8 |
11 |
p. e85-e86 |
artikel |
26 |
The UCL Ventura CPAP device for COVID-19
|
Singer, Mervyn |
|
|
8 |
11 |
p. 1076-1078 |
artikel |